- Home
- DSGX vs CORT Comparison
DSGX vs CORT Comparison
Compare DSGX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- CORT
- Stock Information
- Founded
- DSGX 1981
- CORT 1998
- Country
- DSGX Canada
- CORT United States
- Employees
- DSGX N/A
- CORT N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DSGX Technology
- CORT Health Care
- Exchange
- DSGX Nasdaq
- CORT Nasdaq
- Market Cap
- DSGX 8.4B
- CORT 7.1B
- IPO Year
- DSGX 1999
- CORT N/A
- Fundamental
- Price
- DSGX $104.01
- CORT $83.81
- Analyst Decision
- DSGX Buy
- CORT Strong Buy
- Analyst Count
- DSGX 12
- CORT 4
- Target Price
- DSGX $117.42
- CORT $130.00
- AVG Volume (30 Days)
- DSGX 406.2K
- CORT 2.0M
- Earning Date
- DSGX 03-05-2025
- CORT 04-30-2025
- Dividend Yield
- DSGX N/A
- CORT N/A
- EPS Growth
- DSGX 22.39
- CORT 30.85
- EPS
- DSGX 1.64
- CORT 1.23
- Revenue
- DSGX $651,000,000.00
- CORT $675,040,000.00
- Revenue This Year
- DSGX $13.20
- CORT $36.81
- Revenue Next Year
- DSGX $12.03
- CORT $29.94
- P/E Ratio
- DSGX $60.85
- CORT $74.74
- Revenue Growth
- DSGX 13.63
- CORT 39.94
- 52 Week Low
- DSGX $87.20
- CORT $20.84
- 52 Week High
- DSGX $124.31
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- DSGX 49.88
- CORT 60.19
- Support Level
- DSGX $98.14
- CORT $53.79
- Resistance Level
- DSGX $106.46
- CORT $117.33
- Average True Range (ATR)
- DSGX 2.24
- CORT 6.32
- MACD
- DSGX 0.75
- CORT 4.16
- Stochastic Oscillator
- DSGX 71.64
- CORT 47.25
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.